AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Protagonist Therapeutics, Inc Director's Dealing 2018

Aug 18, 2018

31163_dirs_2018-08-17_46f5fa3c-dac8-48cb-8c0b-86bab04fddb6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2018-08-15

Reporting Person: PATEL DINESH V PH D (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-15	Common Stock	A	82050	$0.00	Acquired	345829	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-15	Stock Option (right to buy)	$8.58	A	54700	Acquired	2028-08-14	Common Stock (54700)	Direct

Footnotes

F1: Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020.

F2: 1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020.